Nasal spray for migraines, generic Advair & more: 5 latest FDA approvals

Here are the five latest drugs or medical devices approved by the FDA since Jan. 25:

1. Wixela Inhub is Mylan's generic version of Advair, an asthma treatment made by GlaxoSmithKline.

2. Tosymra is a sumatriptan nasal spray used to treat migraines in adults.

3. Imbruvica in combination with obinutuzumab is the first nonchemotherapy treatment regimen for some patients with chronic lymphocytic leukemia.

4. Tremfya is now available in a patient-controlled injector formulation to treat psoriasis.

5. Alimta may now be used in combination with Keytruda as a first-line treatment for patients with metastatic, nonsquamous non-small-cell lung cancer.

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars